Biogen News and Research

RSS
New microscope reveals how cells behave in 3D and real time inside living organisms

New microscope reveals how cells behave in 3D and real time inside living organisms

New medication improves motor function in children with later-onset spinal muscular atrophy

New medication improves motor function in children with later-onset spinal muscular atrophy

Extending dosing intervals makes common multiple sclerosis drug safer to use

Extending dosing intervals makes common multiple sclerosis drug safer to use

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

Worsening of anxiety symptoms may be early indicator of Alzheimer's disease

New study discovers key brain circuit implicated in social behavior

New study discovers key brain circuit implicated in social behavior

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Pfizer to stop Alzheimer’s and Parkinson’s disease research

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

Regeneron forms consortium to accelerate largest widely-available human sequencing resource

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Biogen and Ionis awarded 2017 Prix Galien USA Award for SPINRAZA

Drug puts a $750,000 ‘price tag on life’

Drug puts a $750,000 ‘price tag on life’

Pharma, biotech and healthcare industries gender gap

Pharma, biotech and healthcare industries gender gap

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Positive CHMP opinion recognizes efficacy of Biogen’s SPINRAZA for treatment of spinal muscular atrophy

Clinical trials – how can patients get the most benefit out of them?

Clinical trials – how can patients get the most benefit out of them?

MRI as a new tool for MS, with the help of Siemens Healthineers and Biogen

MRI as a new tool for MS, with the help of Siemens Healthineers and Biogen

Johns Hopkins researchers identify new biological target for treating spinal muscular atrophy

Johns Hopkins researchers identify new biological target for treating spinal muscular atrophy

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

Ionis announces FDA approval of first SMA drug in the U.S for pediatric and adult patients

MDA celebrates FDA approval of new spinal muscular atrophy drug

MDA celebrates FDA approval of new spinal muscular atrophy drug

FDA approves first drug to treat children and adults with spinal muscular atrophy

FDA approves first drug to treat children and adults with spinal muscular atrophy

Monoclonal antibody removes brain amyloid plaques in patients with Alzheimer's disease

Monoclonal antibody removes brain amyloid plaques in patients with Alzheimer's disease

First investigational treatment for infantile-onset SMA shows promising results in clinical trial

First investigational treatment for infantile-onset SMA shows promising results in clinical trial

Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK

Daclizumab drug offers new treatment option for people living with relapsing forms of MS in the UK